# Apogee Therapeutics

Type: Company (APGE)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/apogee-therapeutics
Canonical HTML page: https://gethealthbrief.com/entity/apogee-therapeutics

## Recent coverage (1 stories)

### Mixed Analyst Sentiment Hits Biotech: Apogee and Arcturus Under Scrutiny
2026-03-19 14:56:16 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Apogee Therapeutics and Arcturus Therapeutics faced simultaneous downgrades and initiations in a single trading session, highlighting a sharp divide in analyst sentiment. This volatility reflects broader market uncertainty regarding clinical-stage biotech valuations and the specific pipelines of these immunology and mRNA specialists.
Full story: https://gethealthbrief.com/story/biotech-analyst-activity-apogee-arcturus

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.